| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.35 | $1.12 | -17.0% |
| Q4'25 | $1.15 | $1.42 | +23.2% |
| Q3'25 | $1.23 | $1.37 | +11.1% |
| Q2'25 | $1.15 | $1.26 | +9.9% |
| Q1'25 | $0.95 | $1.03 | +8.0% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $2.3B | $2.1B | -8.1% |
| Q4'25 | $2.2B | $2.4B | +10.3% |
| Q3'25 | - | $2.3B | - |
| Q2'25 | - | $2.3B | - |
| Q1'25 | - | $2.1B | - |
Market Data
XYL is currently trading at $110.66, giving Xylem Inc. a market cap of 25.76B and a P/E ratio of 26.3. Today's range spans $110.26–$111.65, with shares opening at $111.11 and moving up $0.38 (0.3%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 67/100.
Over the past year XYL has traded between $105.29 and $154.27 - the current price is +5.1% off the 52-week low and -28.3% from the high.
Earnings estimate risk is at the forefront for Xylem Inc. (XYL) - a large-cap Industrials name (25.76B market cap) showing a SELL (23/100) alongside bullish sentiment (67/100) often flags a period where consensus estimates are still catching down to what the market is already pricing in. Price: $110.66 (near 52-week lows in $105.29–$154.27). (P/E: 26.3) Active managers who track the technical-fundamental gap tend to position ahead of the revision, not after it.
Analyst coverage for XYL becomes a double-edged factor in a SELL phase: at 25.76B in Industrials market cap, active coverage is high enough that downgrade risk is real and impactful. The 23/100 technical reading and bullish sentiment (67/100) at $110.66 (near 52-week lows) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $105.29–$154.27 range establishes where that repricing lands.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines